All news

Privia Health renews Anthem deal. Target for Privia Health stock is USD 31.00

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Privia Health (PRVA) has renewed its agreement with Anthem in Virginia, ensuring continued in-network access for its physicians. The company reported strong second-quarter revenue of USD 632.63 million, a 21.40% year-over-year increase, and analysts maintain a consensus target of USD 31.00 for the stock. Privia Health is set to release its third-quarter 2026 results on November 5, 2026.

Read original source

PRVA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.